Intervention Review

Heparin versus placebo for acute coronary syndromes

  1. Kirk Magee1,*,
  2. Samuel G Campbell1,
  3. David Moher2,
  4. Brian H Rowe3

Editorial Group: Cochrane Heart Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 27 JAN 2008

DOI: 10.1002/14651858.CD003462.pub2

Database Title

Additional Information

How to Cite

Magee K, Campbell SG, Moher D, Rowe BH. Heparin versus placebo for acute coronary syndromes. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD003462. DOI: 10.1002/14651858.CD003462.pub2.

Author Information

  1. 1

    Dalhousie University, Department of Emergency Medicine, Halifax, Nova Scotia, Canada

  2. 2

    Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

  3. 3

    University of Alberta, Department of Emergency Medicine, Edmonton, Alberta, Canada

*Kirk Magee, Department of Emergency Medicine, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax Infirmary, 1796 Summer Street, Halifax, Nova Scotia, B3H 3A7, Canada. kmagee@dal.ca. kmagee@hfx.eastlink.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions), comment added to review
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (294K)Full (358K)

  1. Current Version

    Heparin versus placebo for acute coronary syndromes

    Kirk Magee, Samuel G Campbell, David Moher and Brian H Rowe

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD003462.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Heparin versus placebo for acute coronary syndromes

    K Magee, D Moher and B Rowe

    Article first published online: 23 JAN 2008 | DOI: 10.1002/14651858.CD003462

View Full Article (HTML) Summary (57K)Standard (294K)Full (358K)